The role of Helicobacter pylori (Hp) infection in the pathogenesis of various gastric diseases is an important but unresolved issue. To investigate the association between Hp and the histological findings of the stomach in patients of early gastric cancer, the prevalence of Hp in gastric mucosa and the mucosal alterations were examined histo-pathologically in the surgically resected stomach of 30 cases with early gastric cancer. Serum IgG antibodies for Hp were determined in these cases. All 30 cases had evidence of Hp infection in resected stomach and 90% had Hp antibodies in their serum. There was no evidence of direct association between Hp and gastric cancer histopathologically, although it is considered that chronic gastritis (atrophy and intestinal metaplasia) are implicated in Hp infection.

Download full-text PDF

Source

Publication Analysis

Top Keywords

early gastric
12
gastric cancer
12
helicobacter pylori
8
resected stomach
8
gastric
6
[clinico-pathological study
4
study helicobacter
4
pylori early
4
gastric cancer]
4
cancer] role
4

Similar Publications

Objective: To identify strategies to prevent and treat delayed gastric emptying (DGE) after pancreatic surgery.

Background: Among all complications of pancreatic surgery, DGE has the largest impact on prolonged hospital stay. Several randomized controlled trials (RCTs) have addressed DGE after pancreatic surgery, either as primary or as secondary outcome.

View Article and Find Full Text PDF

Epstein-Barr virus (EBV) contributes to ~1.5% of human cancers, including lymphomas, gastric and nasopharyngeal carcinomas. In most of these, nearly 80 viral lytic genes are silenced by incompletely understood epigenetic mechanisms, precluding use of antiviral agents such as ganciclovir to treat the 200,000 EBV-associated cancers/year.

View Article and Find Full Text PDF

DRAM1 enhances the proliferation and metastasis of gastric cancer through the PI3K/AKT/mTOR signaling pathway and energy metabolism.

Sci Rep

January 2025

Department of Gastroenterology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University of Chinese Medicine, Nanjing, 210000, Jiangsu, China.

Gastric cancer (GC) is a prevalent malignant tumor of the digestive system that is often diagnosed at advanced stages owing to inconspicuous early symptoms and a lack of specific examination methods. Effective treatment of advanced stages remains challenging, emphasizing the need for new therapeutic targets. Metabolic reprogramming, a hallmark of tumors, plays a pivotal role in tumor progression, immune evasion, and immune surveillance.

View Article and Find Full Text PDF

Background: Helicobacter pylori bacteria colonize the gastric mucosa and contribute to the occurrence and development of gastrointestinal diseases. According to the WHO, H. pylori bacteria are considered class I carcinogen.

View Article and Find Full Text PDF

Background: Gastric cancer (GC) ranks as the fourth leading cause of cancer-related deaths worldwide, with most patients diagnosed at advanced stages due to the absence of reliable early detection biomarkers.

Methods: RNA-sequencing was conducted to identify the differentially expressed genes between GC tissues and adjacent normal tissues. CCK8, EdU, colony formation, transwell, flow cytometry and xenograft assays were adopted to explore the biological function of ZBTB10 and betulinic acid (BA) in GC progression.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!